Order Article Reprints

Rashid RSM, Temurlu S, Abourajab A, Karsili P, Dinleyici M, Al-Khateeb B, Icil H. Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations. Pharmaceuticals. 2023; 16(4):555. https://doi.org/10.3390/ph16040555

Rashid, Rebwar Saeed M., Selin Temurlu, Arwa Abourajab, Pelin Karsili, Meltem Dinleyici, Basma Al-Khateeb, and Huriye Icil. 2023. "Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations" Pharmaceuticals 16, no. 4: 555. https://doi.org/10.3390/ph16040555

Rashid, R. S. M., Temurlu, S., Abourajab, A., Karsili, P., Dinleyici, M., Al-Khateeb, B., & Icil, H. (2023). Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations. Pharmaceuticals, 16(4), 555. https://doi.org/10.3390/ph16040555